Inventor
RICHON VICTORIA M
US27 patents
⚠️ This page may combine multiple inventors who share the name “RICHON VICTORIA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SLOAN KETTERING INST CANCER
8 patentsUS6511990B1Jan 28, 2003
Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
SLOAN KETTERING INST CANCER213 citations98
US7148257B2Dec 12, 2006
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
SLOAN KETTERING INST CANCER19 citations91
US7345174B2Mar 18, 2008
Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
SLOAN KETTERING INST CANCER6 citations73
US7063973B2Jun 20, 2006
HDAC9 polypeptides and polynucleotides and uses thereof
SLOAN KETTERING INST CANCER4 citations72
US7879865B2Feb 1, 2011
Treatment of cancer of the brain using histone deacetylase inhibitors
SLOAN KETTERING INST CANCER5 citations63
US7244604B2Jul 17, 2007
HDAC9 polypeptides and polynucleotides and uses thereof
SLOAN KETTERING INST CANCER2 citations61
US7124068B2Oct 17, 2006
Crystal structure of a deacetylase and inhibitors thereof
SLOAN KETTERING INST CANCER2 citations56
US7816499B2Oct 19, 2010
Antibodies that selectively bind HDAC9
SLOAN KETTERING INST CANCER0 citations51
EPIZYME INC
7 patentsUS8691507B2Apr 8, 2014
Inhibitors of human EZH2 and methods of use thereof
EPIZYME INC40 citations96
US9597348B2Mar 21, 2017
Method of treating leukemia
EPIZYME INC15 citations92
US9333217B2May 10, 2016
Inhibitors of human EZH2, and methods of use thereof
EPIZYME INC23 citations91
US9949999B2Apr 24, 2018
Inhibitors of human EZH2, and methods of use thereof
EPIZYME INC10 citations83
US9096634B2Aug 4, 2015
Substituted purine and 7-deazapurine compounds
EPIZYME INC17 citations83
US10881680B2Jan 5, 2021
Method of treating leukemia
EPIZYME INC3 citations72
US11633420B2Apr 25, 2023
Method of treating leukemia
EPIZYME INC0 citations62
MERCK HDAC RES LLC
5 patentsUS7732490B2Jun 8, 2010
Methods of treating cancer
MERCK HDAC RES LLC50 citations95
US7851509B2Dec 14, 2010
Polymorphs of suberoylanilide hydroxamic acid
MERCK HDAC RES LLC20 citations92
US7652069B2Jan 26, 2010
Polymorphs of suberoylanilide hydroxamic acid
MERCK HDAC RES LLC11 citations92
US7399787B2Jul 15, 2008
Methods of treating cancer with HDAC inhibitors
MERCK HDAC RES LLC32 citations91
US7375137B2May 20, 2008
Methods of treating cancer with HDAC inhibitors
MERCK HDAC RES LLC27 citations91
UNIV COLUMBIA
3 patentsUS7126001B2Oct 24, 2006
Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
UNIV COLUMBIA16 citations92
US7199134B2Apr 3, 2007
Hydroxamic acid compounds and methods of use thereof
UNIV COLUMBIA8 citations74
US7799803B2Sep 21, 2010
Hydroxamic acid compounds and methods of use thereof
UNIV COLUMBIA0 citations52